AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
SciSparc shares surge 31.07% premarket after NeuroThera acquires 55% stake in quantum computing bio data company.
ByAinvest
Friday, Dec 5, 2025 5:24 am ET1min read
SciSparc Ltd. (SPRC) surged 31.07% in premarket trading following news that Neurothera Labs signed a non-binding term sheet to acquire a 55% stake in a quantum computing bio data company under its portfolio. The deal, though non-binding, signals strategic interest in SciSparc’s technology and could enhance its market position in the emerging quantum computing sector. The heightened media sentiment score (2/2) and increased news coverage over the past week further underscore growing investor confidence. This development aligns with the stock’s sharp premarket rally, reflecting optimism around potential collaboration and value creation.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet